PML Antikörper
-
- Target Alle PML Antikörper anzeigen
- PML (Promyelocytic Leukemia (PML))
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser PML Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA
- Kreuzreaktivität
- Human
- Kreuzreaktivität (Details)
- Calculated cross reactivity: Hu
- Produktmerkmale
- PML (Probable Transcription Factor PML, RING Finger Protein 71, Tripartite Motif-containing Protein 19, PML, MYL, RNF71, TRIM19)
- Aufreinigung
- Purified by Protein G affinity chromatography.
- Immunogen
- Recombinant corresponding to partial human PML.
- Klon
- 12K276
- Isotyp
- IgG1 kappa
- Top Product
- Discover our top product PML Primärantikörper
-
-
- Applikationshinweise
- Optimal working conditions should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Reconstitute in ddH2O to 1 mg/mL.
- Buffer
- Supplied as a lyophilized powder from 0.01M PBS, pH 7.4.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- -20°C
-
- Target
- PML (Promyelocytic Leukemia (PML))
- Andere Bezeichnung
- PML (PML Produkte)
- Synonyme
- MYL antikoerper, PP8675 antikoerper, RNF71 antikoerper, TRIM19 antikoerper, 1200009E24Rik antikoerper, AI661194 antikoerper, Trim19 antikoerper, RGD1562602 antikoerper, PML antikoerper, promyelocytic leukemia antikoerper, PML antikoerper, Pml antikoerper
- Pathways
- p53 Signalweg, Retinoic Acid Receptor Signaling Pathway, Maintenance of Protein Location, Positive Regulation of Endopeptidase Activity, Protein targeting to Nucleus
-